Rockbridge Investment Management, Lcc Seagen Inc. Transaction History

Rockbridge Investment Management, Lcc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.0 - $228.9 $0 - $22,890	-100 Closed	0 $0
Q3 2022 May 28, 2024	SELL	$135.27 - $180.11 $13,527 - $18,011	-100 Closed	0 $0
Q1 2022 May 28, 2024	BUY	$119.61 - $157.85 $11,961 - $15,785	100 New	100 $14,000
Q4 2020 Mar 04, 2021	BUY	$164.63 - $211.93 $16,463 - $21,193	100 New	100 $18,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.